![Douglas Carr](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Douglas Carr
Finansdirektör/CFO på
CENTURY THERAPEUTICS, INC.
Förmögenhet: 1 M $ per 2026-05-31
Profil
Currently, Douglas Carr is Director at Heritage Conservancy, Chief Financial Officer & Secretary at Century Therapeutics, Inc. starting in 2025, and Vice President-Finance at Novira Therapeutics, Inc. since 2018.
Former positions include Business Director-Franchise Division at Zocor Ltd., Controller-Pediatric Vaccines Franchise at Merck & Co., Inc., Financial Controller at Omthera Pharmaceuticals, Inc., and Vice President-Finance & Operations at Century Therapeutics, Inc. Education includes an undergraduate degree from Rutgers State University of New Jersey.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-06-12 | 505 094 ( 0,28 % ) | 1 M $ | 2026-05-31 |
Aktiva positioner av Douglas Carr
| Företag | Position | Start |
|---|---|---|
| CENTURY THERAPEUTICS, INC. | Finansdirektör/CFO | 2025-07-11 |
Novira Therapeutics, Inc. | Företagsledare/Principal | 2018-10-01 |
Heritage Conservancy
 Heritage Conservancy Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit organization for land conservation, historic preservation and community education | Direktör/Styrelseledamot | - |
Tidigare kända positioner av Douglas Carr
| Företag | Position | Slut |
|---|---|---|
Century Therapeutics, Inc. /Old/
 Century Therapeutics, Inc. /Old/ BiotechnologyHealth Technology Operates as a biotechnology company | Finansdirektör/CFO | - |
| MERCK & CO., INC. | Företagsledare/Principal | - |
Zocor Ltd. | Företagsledare/Principal | - |
Omthera Pharmaceuticals, Inc.
 Omthera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as pharmaceuticals company which focuses on the clinical development of new therapies for dyslipidemia | Comptroller/Controller/Revisor | - |
Douglas Carrs utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
1
Första gradens relationer
8
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 8 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Omthera Pharmaceuticals, Inc.
Omthera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as pharmaceuticals company which focuses on the clinical development of new therapies for dyslipidemia | Health Technology |
Rutgers State University of New Jersey
 Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Zocor Ltd. | |
Heritage Conservancy
Heritage Conservancy Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit organization for land conservation, historic preservation and community education | Commercial Services |
Century Therapeutics, Inc.
 Century Therapeutics, Inc. BiotechnologyHealth Technology Develops novel allogeneic living drugs for oncology that overcome the limitations of first-generation cell therapies | Health Technology |
Century Therapeutics, Inc. /Old/
Century Therapeutics, Inc. /Old/ BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Novira Therapeutics, Inc. | Electronic Technology |
